Man Mohan
Shanghai Key Laboratory Of Tumor Microenvironment And Inflammation
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity.
Journal: eLife
Published: October 22, 2024
DYRK1B phosphorylates FOXO1 to promote hepatic gluconeogenesis.
Journal: Nucleic acids research
Published: May 16, 2024
K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR.
Journal: Cell death & disease
Published: October 17, 2020
PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 25, 2019
Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
Journal: Nature communications
Published: January 29, 2019
DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers.
Journal: Nucleic acids research
Published: September 14, 2017
miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
Journal: Cell death & disease
Published: November 26, 2016
miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Journal: Molecular cancer
Published: November 20, 2016
MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: October 26, 2016
Last Updated: 09/26/2026